Position in RYTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$300,891
+$300,891 QoQ
Shares Held
2,710
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#214
of 299 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Derivatives in RYTM
reported options exposure · as of Jun 30, 2026CallValue
$3,008,913
CallShares
27,100
PutValue
$2,664,720
PutShares
24,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,130,252 across 291 Biotechnology names. RYTM ranks #152 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in RYTM
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,664,720 | 24,000 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $3,008,913 | 27,100 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $300,891 | 2,710 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $339,183 | 3,900 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $4,044,105 | 46,500 | Call | Defined | 2026-05-12 | |
| 2025-12-31 | $209,798 | 1,960 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $14,739,408 | 137,700 | Call | Defined | 2026-02-12 | |
| 2025-09-30 | $7,372,270 | 73,000 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $299,738 | 2,968 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $1,484,553 | 14,700 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $4,398,024 | 69,600 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $3,330,113 | 52,700 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $9,010,197 | 170,100 | Call | Defined | 2025-05-19 | |
| 2025-03-31 | $4,826,519 | 91,118 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $3,270,070 | 58,415 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $5,486,040 | 98,000 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $9,760,257 | 186,300 | Call | Defined | 2024-11-15 | |
| 2024-09-30 | $5,720,253 | 109,186 | Shares | Defined | 2024-11-15 | |
| 2024-09-30 | $979,693 | 18,700 | Put | Defined | 2024-11-15 | |
| 2024-06-30 | $6,015,289 | 146,500 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $1,140,357 | 26,318 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $8,474,982 | 184,359 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $3,301,245 | 144,002 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,253,635 | 76,024 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,237,558 | 349,639 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $5,809,526 | 199,503 | Shares | Defined | 2023-02-15 | |
| 2022-03-31 | $217,992 | 18,923 | Shares | Defined | 2022-05-17 | |
| 2021-03-31 | $250,347 | 11,770 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $262,753 | 8,838 | Shares | Defined | 2021-02-17 | |
| 2020-06-30 | $211,961 | 9,505 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $182,959 | 12,021 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||